Insights

Active Investment Portfolio Advent Life Sciences has recently invested in promising biotechnology and medtech startups such as Artax Biopharma, Moximed, and Proximie, showcasing ongoing opportunities to collaborate or provide advanced technological solutions to their portfolio companies.

Strong Industry Focus Focused on early to mid-stage companies in drug discovery, biologics, and medical technologies, Advent offers potential sales opportunities in innovative research tools, laboratory equipment, and advanced biotech platforms tailored to their investment sectors.

Collaborative Partnership Approach Advent actively partners with companies like Wondr Medical and F2G Ltd, highlighting openings for service providers and vendors that can support their partners in clinical development, medical engagement, and fungal infection treatments.

Regional Market Presence Headquartered in London with investment activity across the UK, Europe, and the USA, there's a strategic opportunity for regional or global solution providers to engage with them across multiple markets.

Scaling Financial Growth While currently reporting revenues between one and ten million dollars, Advent’s active funding rounds and investments in high-growth biotech firms suggest potential for expanding vendor relationships aligned with their future funding and commercialization phases.

Advent Life Sciences Tech Stack

Advent Life Sciences uses 8 technology products and services including Sucuri, MySQL, imagesLoaded, and more. Explore Advent Life Sciences's tech stack below.

  • Sucuri
    Content Delivery Network
  • MySQL
    Database
  • imagesLoaded
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • X-XSS-Protection
    Security
  • Google Tag Manager
    Tag Management
  • GoDaddy
    Web Hosting
  • Apache HTTP Server
    Web Servers

Media & News

Advent Life Sciences's Email Address Formats

Advent Life Sciences uses at least 1 format(s):
Advent Life Sciences Email FormatsExamplePercentage
First.Last@adventls.comJohn.Doe@adventls.com
45%
First@adventls.comJohn@adventls.com
5%
First.Last@adventls.comJohn.Doe@adventls.com
45%
First@adventls.comJohn@adventls.com
5%

Frequently Asked Questions

Where is Advent Life Sciences's headquarters located?

Minus sign iconPlus sign icon
Advent Life Sciences's main headquarters is located at London, England United Kingdom. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Advent Life Sciences's official website and social media links?

Minus sign iconPlus sign icon
Advent Life Sciences's official website is adventls.com and has social profiles on LinkedIn.

What is Advent Life Sciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Advent Life Sciences's SIC code is 6371 - Pension, Health, and Welfare Funds NAICS code is 52391 - Miscellaneous Intermediation.

How many employees does Advent Life Sciences have currently?

Minus sign iconPlus sign icon
As of March 2026, Advent Life Sciences has approximately 27 employees across 3 continents, including EuropeAsiaNorth America. Key team members include General Partner: S. J.General Partner: K. M.Owner: P. K.. Explore Advent Life Sciences's employee directory with LeadIQ.

What industry does Advent Life Sciences belong to?

Minus sign iconPlus sign icon
Advent Life Sciences operates in the Venture Capital and Private Equity Principals industry.

What technology does Advent Life Sciences use?

Minus sign iconPlus sign icon
Advent Life Sciences's tech stack includes SucuriMySQLimagesLoadedMicrosoft WordX-XSS-ProtectionGoogle Tag ManagerGoDaddyApache HTTP Server.

What is Advent Life Sciences's email format?

Minus sign iconPlus sign icon
Advent Life Sciences's email format typically follows the pattern of First.Last@adventls.com. Find more Advent Life Sciences email formats with LeadIQ.

When was Advent Life Sciences founded?

Minus sign iconPlus sign icon
Advent Life Sciences was founded in 2005.

Advent Life Sciences

Venture Capital and Private Equity PrincipalsEngland, United Kingdom11-50 Employees

Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and investment success through turning break-through science into approved medicines or medical products.

We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines.

As entrepreneurs and experienced, pragmatic investors, we bring the intellectual capital of our well connected team to support each investment. We work in close alignment with our management teams, and partner with them to realise their vision - achieving superior financial returns by bringing innovation to patients.

The companies in which we have invested since the year 2000 have discovered and developed, fourteen approved medicines and products - to the benefit of patients, physicians and our investors.

Section iconCompany Overview

Headquarters
London, England United Kingdom
SIC Code
6371 - Pension, Health, and Welfare Funds
NAICS Code
52391 - Miscellaneous Intermediation
Founded
2005
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Advent Life Sciences's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Advent Life Sciences's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.